At the Institute.
We are fortunate to have filled the position of Executive Director with a highly capable individual. Tracey Bailey brings a wealth of practice and teaching experience to the position. For the past two years she has been the HLI's Project Manager. In that capacity, she became an indispensable part of the HLI team. Tracey expanded our public outreach programs, took charge of the publications and led a variety of research projects. Given her incredible enthusiasm, leadership and administrative skills, I know the HLI is in good hands.
It also gives me pleasure to announce that Nola Ries has joined the HLI staff as Project Manager/Research Associate. Nola, who recently completed her LL.M. in health law, has a strong background in constitutional and human fights law. She has already played a critical role in several research initiatives, including championing a project on the public health law issues associated with the SARS outbreak. We are very excited to have Nola on board.
The HLI has commenced a number of exciting new research projects. We are in the process of building links with the University of Alberta National Institute for Nanotechnology (NINT). Over the next year, Lori Sheremeta, Research Associate, will be spending a significant amount of time helping to work with the local and national community in order to build a "nanoethics" research team. Finally, we are happy to announce that the HLI is part of a new National Centre of Excellence, the Food Biotechnology Network (led by Rick Yada from the University of Guelph). This project will allow us to study the legal issues associated with regulation of food biotechnology, complementary medicine and the patenting of higher life forms.
Finally, I would like to end by recognizing a ten year anniversary. Nina Hawkins and I joined the Institute in 1993. Nina is the heart and soul of the HLI. Thanks for a wonderful decade!
Canada Research Chair in Health Law & Policy
|Printer friendly Cite/link Email Feedback|
|Publication:||Health Law Review|
|Date:||Sep 22, 2003|
|Previous Article:||Paternalistic or protective? Freedom of expression and direct-to-consumer drug advertising policy in Canada.|
|Next Article:||Spare embryos and stem cell research: consent issues.|
|Crash tests yield data, safer autos.|
|Behind the green curtain.|